Clinical trial
Pneumococcal Vaccination of Fiji Infants
NCT00170612 · University of Melbourne, Other · Completed
Key facts
| NCT number | NCT00170612 |
|---|---|
| Title | Pneumococcal Vaccination of Fiji Infants |
| Official title | A Single-Blind Open-Label Randomized Phase II Study of the Safety, Immunogenicity and Impact on Pneumococcus (Pnc) Carriage of the Pnc Vaccination Regimens Combining 1, 2, or 3 Doses of 7-Valent Pneumococcal Conjugate Vaccine (PCV) in the First 4 Months of Life Followed by a Single Dose of 23-Valent… |
| Lead sponsor | University of Melbourne, Other |
| Collaborators | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pneumococcal Infections |
| Intervention type | Biological |
| Interventions | Pneumovax 23, Prevnar |
| Enrollment | 552 |
| Start date | Nov 1, 2005 |
| Primary completion | Jan 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 21, 2008 |
| Countries | Fiji |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: